Salute e Benessere

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial in…

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial in myasthenia gravis at the 28 thInternational Annual Congress of the World Muscle Society NMD Pharma will show the first ever clinical proof-of-mechanism for the novel concept of ClC-1 inhibition with NMD670 in treatment of neuromuscular diseases demonstrated in patients with myasthenia gravis The data provides clinical validation of the ability of CIC-1 inhibition to restore...
Nasdaq GlobeNewswire
03/10/2023

Parkinson's Disease Psychosis Market is Likely to Increase at a Steady Growth…

Key Takeaways from the Parkinson's Disease Psychosis Market Report Key Takeaways from the Parkinson's Disease Psychosis Market Report Discover which therapies are expected to grab the major Parkinson's disease psychosis market share @Parkinson's Disease Psychosis Market Report Parkinson's Disease Psychosis Overview Parkinson's disease psychosis (PDP) is a complex and often distressing complication that can affect individuals living with Parkinson's disease. This condition is...
PR Newswire
02/10/2023

3B Scientific acquires Wallcur

Wallcur, a respected name in healthcare simulation for over 40 years, has earned a reputation for its innovative and high-quality simulated medicine products that enhance medical education across the globe. Wallcur's mission is to provide ideas and products that both stimulate and simulate clinical learning in a safe non-clinical environment to help graduate the most competent, confident, and ready practitioner for today's healthcare system. By joining forces with Wallcur, 3B Scientific aims to…
PR Newswire
02/10/2023

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq…

NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION OCTOBER 2, 2023, 4:00pm ET / 22:00 CETMDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq andConvenes an Extraordinary General Shareholders MeetingIRVINE, CA, and HERSTAL, BELGIUM– October 2, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announces a proposed transition from a dual listing of the...
Nasdaq GlobeNewswire
02/10/2023

MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF…

Nicox SA Société anonyme with a registered capital of € 50,170,498 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 2, 2023, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlementgénéral of the l'AMF) As of September 30, 2023 Total number of...
Nasdaq GlobeNewswire
02/10/2023

Blood Screening Market worth $3.4 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Browse in-depth TOC on "Blood Screening Market" 189 - Tables 45 - Figures 220 - Pages Blood Screening Market Scope: The Reagents & Kits segment is expected to account for the largest share in 2022. Based on product, the blood screening market is segmented...
PR Newswire
02/10/2023

TATAA Biocenter appoints Johanna Nilsson as new Head of Marketing to strengthen…

Johanna Nilsson brings seven years of comprehensive marketing experience, ranging from strategic planning to implementation. Most recently, she served at Kromnigon, a biotech company located at the heart of the BioVentureHub within the AstraZeneca R&D complex. Johanna Nilssonbrings seven years of comprehensive marketing experience, ranging from strategic planning to implementation. Most recently, she served at Kromnigon, a biotech company located at the heart of the BioVentureHub within…
PR Newswire
02/10/2023

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan

The research collaboration agreement (RCA) between Vela Diagnostics and SRL Inc was signed in June 2023, marking a significant milestone in their shared commitments to advancing healthcare solutions in Japan. Vela Diagnostics aims to capitalize on SRL Inc's comprehensive distribution network and market understanding, enabling the company to introduce its Sentosa® SQ HIV-1 Genotyping Assay Kit to Japanese healthcare and diagnostic institutions. The research collaboration agreement (RCA)…
PR Newswire
02/10/2023

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to…

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MDLOS ANGELES, Oct.02, 2023(GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (Nasdaq: RENB)Dear Shareholders,I am writing to provide you with an update on our recent news of signing a definitive agreement to combine with GEDiCube ( GEDiCube Press Release ) ( Renovaro Press Release ) and to share our vision for the promising future of our newly combined company if you, as shareholders, approve the agreement. As we embark on...
Nasdaq GlobeNewswire
02/10/2023

KENNAMETAL EXPANDS HARVI PORTFOLIO AND PERFORMANCE WITH FIRST-EVER 8-FLUTE END…

"Our first 8-flute end mill will move customers from one challenging cut to the next without having to stop for tool changes," said Scott Etling, Vice President of Marketing, Global Product Management. "Machinists need to achieve high productivity when working on tougher materials while remaining cost-effective. Our new HARVI IV 8-Flute End Mills deliver just that and were designed especially for roughing and finishing applications that requires a combination of flexibility and…
PR Newswire
02/10/2023

Novo Nordisk A/S - share repurchase programme

Bagsværd , Denmark, 02October 2023– On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023...
Nasdaq GlobeNewswire
02/10/2023

ZEISS and Boehringer Ingelheim join forces to develop early detection of eye…

The new partnership will focus on identifying markers of early stages of retinal diseases by leveraging ZEISS Medical Technology's cloud-connected devices and AI-assisted analysis of massive image data sets. This will provide a basis for clinical studies for development of more personalized and precise treatments of early stages of chronic retinal disease as well as earlier detection and prediction capabilities to preserve vision through new treatment pathways. The new partnership will focus…
PR Newswire
02/10/2023

Enable Injections Receives First U.S. Food and Drug Administration (FDA)…

"The approval of the EMPAVELI Injector will enhance the patient experience of administering a large volume (20 mL) of subcutaneous therapy," said Michael D. Hooven, Enable Injections' Chairman and CEO. "Enable's purpose is to redefine drug delivery for the benefit of patients. We are excited about achieving this milestone and are looking forward to growing enFuse® partnerships to improve the patient experience around the world." "The approval of the EMPAVELI Injector…
PR Newswire
02/10/2023

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

uniQure N.V.(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant of inducement equity awards to newly hired employees. The Company granted equity awards to 42 employees as a material inducement to commencing their employment. In the aggregate, those employees received 98,900 restricted share units and options to purchase 90,500 ordinary shares of the Company. Each option has an exercise price of...
Nasdaq GlobeNewswire
02/10/2023

Global Mobile Air Transfer Mats Market to be Driven by Growing Demand for…

The global market for mobile air transfer mats is expected to grow significantly in the coming years, driven by several factors, including the overall increasing healthcare expenditure. The globalmarket for mobile air transfer mats is expected to grow significantly in the coming years, driven by several factors, including the overall increasing healthcare expenditure. Mobile Air Transfer Mats Market Overview 2023 – 2033: Request to Download Sample Report: https://www...
PR Newswire
02/10/2023

Redefining Scrub Typhus Disease Landscape with DLI's Unmet Needs, Drug Insights…

Disease Landscape Insights Healthcare Consulting Services has been playing a significant role in advancing the efforts of scrub typhus stakeholders within the realms of drug development and clinical trial assessment while offering product launch services. By meticulously evaluating disease prevalence, it facilitates treatment gaps identification that are crucial for directing research and development strategies. Its expertise further extends to clinical trial feasibility analysis, enabling…
PR Newswire
02/10/2023

Unlocking the Prostate Cancer Market: DLI's Extensive Disease Insights, Unmet…

The industry participants are making efforts to solidify their footprint in the prostate cancer management vertical. DLI with its oncology consulting expertise has been empowering these players in term of market access, price reimbursement strategies, regulatory insights and commercial strategy analysis, just to name a few. The industry participants are making efforts to solidify their footprint in the prostate cancer management vertical. DLI with its oncology consulting expertise has been...
PR Newswire
02/10/2023

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

"When we began this project in 2021, our vision extended far beyond capacity," saidTom Loewald, CEO, Cambrex. "We designed a facility that can continue to deliver on client needs as the industry evolves, with state-of-the-art technology and laboratory equipment, an energy-efficient infrastructure, and clinical to commercial manufacturing scale." TheHigh Pointcapabilities complement those of previously acquired Snapdragon Chemistry, which specializes in R&D for API batch…
PR Newswire
02/10/2023

Promising Therapies Revitalize the Gastric Cancer Market :Empowering with Drug…

Disease Landscape Insights have been helping players to navigate through the complexities of stomach cancer management. It is empowering them with ideal market entry strategy, price and market access plans, regulatory consulting advices, along with overall disease insights. DLI's market intelligence expertise has been assisting players in treatment gaps identification along with the determination of market barriers. DLI healthcare consulting services further equips the industry participants…
PR Newswire
02/10/2023

Reshaping Crohn's Disease Market: Epidemiology Study, Drug Insights, Clinical…

Disease Landscape Insights has been offering healthcare consulting services to the industry participants in the form of stakeholders, pharma companies, medical research firms, healthcare organizations, and biotech firms, among others. Its primary aim is to empower them with crucial disease insights which can help them solidify their position. They further rely on DLI's assistance in terms of price reimbursement, market access, clinical trial management, regulatory guideline adherence, and drug…
PR Newswire
02/10/2023

Multiple System Atrophy (MSA) Market - Drug Development, Clinical Trials…

MSA Prevalence- A global health hazard: MSA Prevalence- A global health hazard: This disorder poses significant threat to a patient's quality of life, obstructing their day-to-day activities at large. MSA life expectancy may vary from person to person but on an average a patient may live 6-9 years from the time of detection. It is crucial to determine the MSA risk factors at an early stage so that professionals can accurately formulate MSA coping strategies. Medical scientists and...
PR Newswire
02/10/2023

Navigating the Anaemia Disease Landscape: Market Insight Epidemiology, Forecast…

Disease Overview- Causes and Symptoms: Disease Overview- Causes and Symptoms: This life threating illness has been impacting a large proportion of the global population. Causes of low iron and low haemoglobin causes may vary from person to person. But the major factors can be nutritional deficiencies, aging, unhealthy lifestyle habits, certain medications, genetic defects, pregnancy, and blood loss, among others. Symptoms of anaemia in pregnancy may be temporary and can be managed with...
PR Newswire
02/10/2023

VIRBAC: MAR Weekly Report_VIRBAC SA_25 to 29 September 2023

Statement of transactions in own shares from September 25, 2023 to September 29, 2023BNP PARIBAS EXANE Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price...
Nasdaq GlobeNewswire
02/10/2023

MedAlliance Acquired by Cordis for up to USD 1.135 Billion

"The Cordis acquisition will accelerate access to this breakthrough technology for patients around the globe suffering from coronary and peripheral disease," said Jeffrey B. Jump, Founder, Chairman and CEO of MedAlliance. "I want to thank our entire MedAlliance team - including physicians, distributors and clinical patients - who have succeeded in disrupting the coronary and peripheral markets to provide a safe and effective new technology. The arsenal of SELUTION SLR DEB clinical…
PR Newswire
02/10/2023
Altri  Comunicati